Member Info for mhgoddard

All the shorts appear to be reducing, this should assist in regaining momentum, along with the seemingly unstoppable hunger for AI / data centres globally.

I would think that Goodwin will be well placed for valve orders from the distruction in the Gulf. Also their radar equipment will be in demand. This on top of their current order book.

That's strange as I bought some at about 11am on the corporate action via II...

Sorcerer, that makes a great deal of sense to me and the reduced period between doses is enabled by the massive reduction in side effects as a result of the targeted drug.

Have a look at Dr John Campbell's latest video. He has analysed recent data from across the pond which confirms that natural infection provides enhanced protection compared to vaccines. He also argues that AB tests should be used instead of the blind roll out of boosters. I would suggest that AB tests could also be used by healthcare providers to confirm that unvaccinated staff who have been infected pose no greater risk to patients than their vaccinated colleagues.

Thanks for the reply Davde, as you say, if they are rolling out the Pfizer / Biontech vaccine next week you would expect this to be widely publicised and use of an antibody test - before to confirm if the potential recipient already has antibodies and then after to confirm the vaccine works would be evident and probably communicated in some sort of process map. It would be prudent and responsible, inspite of the rigorous testing of the vaccine to complete this testing, particularly in the early stages of role out of a new product instead of assuming that by administering it that it works, particularly with the temperature issues.

Has any one got any evidence that our antibody test will be used hand in hand with the Pfizer Biontech vaccine?